Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.
Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says
The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday.The markups helped the PBMs reap $7.
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
FTC finds PBMs excessively marked up prices on specialty drugs
A new report issued by the Federal Trade Commission has found that prescription benefit manager units owned by CVS Health (NYSE:CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked up prices for many specialty generic drugs over a six-year period.
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.
17h
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January ...
8h
on MSN
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
8h
on MSN
Cigna Group stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
11h
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3)
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
9h
on MSN
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
STAT
1d
Cigna, Centene, Walgreens drop out of J.P. Morgan conference
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
6d
Cigna Group stock underperforms Wednesday when compared to competitors
Cigna Group closed $91.51 below its 52-week high ($370.83), which the company achieved on September 16th.
7d
Here's How Much $1000 Invested In Cigna 15 Years Ago Would Be Worth Today
Buying $1000 In CI: If an investor had bought $1000 of CI stock 15 years ago, it would be worth $7,625.07 today based on a ...
6d
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Federal Trade Commission
UnitedHealth Group
Feedback